Intermittent Courses of Corticosteroids Also Present a Risk for Pneumocystis Pneumonia in Non-HIV Patients
Introduction. Pneumocystis pneumonia (PCP) is rising in the non-HIV population and associates with higher morbidity and mortality. The aggressive immunosuppressive regimens, as well as the lack of stablished guidelines for chemoprophylaxis, are likely contributors to this increased incidence. Herein...
Main Authors: | Maria L. Calero-Bernal, Isabel Martin-Garrido, Mikel Donazar-Ezcurra, Andrew H. Limper, Eva M. Carmona |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2016/2464791 |
Similar Items
-
Adjunctive Corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia
by: Norihiko Inoue, et al.
Published: (2019-02-01) -
Positive Pneumocystis jirovecii Sputum PCR Results with Negative Bronchoscopic PCR Results in Suspected Pneumocystis Pneumonia
by: Kelly Pennington, et al.
Published: (2018-01-01) -
Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: A strategy for prevention
by: Carmichael Andrew J, et al.
Published: (2004-10-01) -
Pneumocystis pneumonia
by: Atousa HAKAMIFARD, et al.
Published: (2019-12-01) -
Pneumocystis Pneumonia
by: Jang-Jih Lu, et al.
Published: (2008-11-01)